EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Alzheimer's disease: general methodological aspects



Treatment of Alzheimer's disease: general methodological aspects



Revue Neurologique 160(2): 261-264



The availability of many etiological hypothesis for Alzheimer's disease raise the possibility of treatments aiming at slowing down disease progression. Clinical trial designs and relevant outcomes are available to test these hypothesis. A preventive approach based on individual risk assessment may be possible, which will increase the number of consultations for neurologists in the near future.

(PDF 0-2 workdays service: $29.90)

Accession: 035980327

Download citation: RISBibTeXText

PMID: 15034487



Related references

Methodological aspects of comparative research in the epidemiology of Alzheimer disease. American Journal of Geriatric Psychiatry 10(4): 373-385, 2002

Methodological aspects and discrepancies in the clinical trials in Alzheimer's disease. Revista de Neurologia 23(119): 125-128, 1995

A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders 11 Suppl 2: S1-12, 1997

Methodological issues in estrogen treatment trials for Alzheimer's disease. Annals of the New York Academy of Sciences 1052: 173-181, 2005

Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations. Drugs & Aging 21(5): 279-295, 2004

Methodological Aspects of the Phase II Study AFF006 Evaluating Amyloid-beta -Targeting Vaccine AFFITOPE® AD02 in Early Alzheimer's Disease - Prospective Use of Novel Composite Scales. Journal of Prevention of Alzheimer's Disease 2(2): 91-102, 2016

Care of cancer patients in 31 italian general hospitals methodological aspects and general findings. European Journal of Cancer & Clinical Oncology 19(2): 179-186, 1983

Care of cancer patients in thirty-one Italian general hospitals. Methodological aspects and general findings. European Journal of Cancer & Clinical Oncology 19(2): 179-185, 1983

A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments. Dementia 15(2): 239-254, 2016

What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population?. Alzheimer's Research & Therapy 3(2): 13-13, 2011

The pharmacologic treatment of Alzheimer's disease: a guide for the general psychiatrist. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 43(7): 689-697, 1998

Immunological aspects of the treatment of various forms of Alzheimer's disease. Psychiatria Polska 23(5-6): 373-378, 1989

Trace elements in end-stage renal disease. 1. Methodological aspects and the influence of water treatment and dialysis equipment. Blood Purification 17(4): 182-186, 1999

Pharmacoeconomic aspects of memantine (Ebixa) in the treatment of Alzheimer's disease. Expert Review of Pharmacoeconomics & Outcomes Research 3(6): 675-680, 2003

The role of general practitioners in the diagnosis and treatment of Alzheimer's disease: a multinational survey. Journal of International Medical Research 32(2): 149-159, 2004